Study to Assess the Safety and Effectiveness of NMRA-335140-501

Recruiting

Phase 3

Study to Assess the Safety and Effectiveness of NMRA-335140-501Study to Assess the Safety and Effectiveness of NMRA-335140-501

Sponsor:

Neumora Therapeutics, Inc.

Code:

NCT06029439

Conditions

Major Depressive Disorder

Eligibility Criteria

Sex: All

Age: 18 - 65

Healthy Volunteers: Not accepted

Interventions

NMRA-335140

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-03-31. This information was provided to ClinicalTrials.gov by Neumora Therapeutics, Inc. on 2025-03-27.